High Powered Stone Dusting vs. Fragmentation and Basketing at Time of Ureteroscopy
Launched by NORTHWESTERN UNIVERSITY · Aug 13, 2021
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods for treating kidney and ureteral stones (stones located in the tube between the kidney and bladder) that are 6 mm or larger. The two methods being compared are called "dusting," where a laser breaks the stone into tiny pieces that can be passed in urine, and "basket extraction," which involves using a small wire basket to remove the stone fragments directly. The goal of the study is to see which method results in more successful removal of the stones, fewer side effects, and higher satisfaction among patients.
To be eligible for this trial, participants need to be at least 18 years old, undergoing ureteroscopic stone removal, and have stones that are 6 mm or larger located in the mid ureter or higher. They must also be able to read and answer questions about their experience. If you join the study, you can expect to receive treatment using one of the two methods and answer some questions about your pain and satisfaction after the procedure. The trial is currently looking for participants, and it’s important to know that individuals who have certain medical conditions or lack access to a phone for communication may not be eligible to participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • \>18 years of age
- • undergoing ureteroscopic stone extraction
- • Stone size 6mm stones or greater and the location to mid ureter or higher
- • Willing to sign informed consent form
- • Able to read, understand, and complete patient questionnaires, and pain questionnaires
- Exclusion Criteria:
- • \< 18 years of age
- • Inability to provide informed consent
- • Concomitant surgery (i.e. Percutaneous nephrolithotomy, Holmium laser enucleation of the prostate
- • Solitary kidney
- • Nephrocalcinosis
- • Members of vulnerable patient populations
- • Patients without access to a phone that can receive txt messages
About Northwestern University
Northwestern University is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a robust infrastructure that supports interdisciplinary collaboration, Northwestern leverages its expertise in various fields, including medicine, engineering, and social sciences, to drive groundbreaking studies. The university is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring that all clinical trials are conducted with the utmost integrity and focus on participant safety. Through its Clinical Trials Office, Northwestern aims to translate scientific discoveries into effective therapies, ultimately enhancing health outcomes and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Amy Krambeck, MD
Principal Investigator
Northwestern University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials